REGINA GARCÍA DELGADO – ENSAYO CLÍNICO CON MEDICAMENTOS – NUMAB THERAPEUTICS AG
A First-In-Human Phase 1/2 Study of NM32-2668 (Anti-ROR1/Anti-CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients With Advanced Hematological Tumors
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - B-03 | 0 comments